The Impact of Time Restricted Eating on Type 2 Diabetes
NCT06887543 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2026-01-20
Summary
Time-restricted feeding limits caloric intake to active daytime hours with fasting for 14 to 16 hours. It has shown great promise as a novel intervention for stabilizing blood glucose, reducing weight, and improving cardiovascular disease outcomes. However, this approach has not been tested on people with diabetes, a group that would benefit from improved blood glucose and weight loss.
The impact of Time-Restricted Eating on Type 2 Diabetes Study (EaT2D Study) is a randomized six-day weight stable crossover feeding study in the Day Patient/Outpatient unit of The Rockefeller Hospital investigating how the time of day that meals are eaten affects weight, blood sugar and blood pressure. The investigators will compare an early time-restricted eating intervention (80% of calories consumed before 2 pm) to a usual feeding pattern (50% of calories consumed after 4 pm) among 10 persons with type 2 diabetes to determine effects on blood sugar and small molecules found in the blood.
Studies have shown benefits of eating during active periods (mornings and early afternoon) for metabolic health (blood sugar, body weight) compared to eating during inactive periods (evening and bedtime). Eating earlier in the day may lead to reduced sugar stores, burning fat for energy, and decreased inflammation when compared to eating later in the day. The investigators will compare the effects of eating earlier during the day for six days versus later in the day for six days, on blood sugar, blood pressure, blood ketones, and other measures of metabolic health in diabetic participants. Studies in animals supports these benefits.
Conditions
Interventions
- OTHER
-
Meal timing
Participants either eat all of their daily calories between 8 AM and 4 PM with 16 hours fasting for six days, or they eat the same meals ad lib daily for six days. After post-testing, they crossover to the other arm.
- OTHER
-
Time restricted eating
Eating restricted to 8 AM - 2 PM for 80% of caloric intake, the remaining 20% consumed by 4 PM, subsequent 16-hour fasting (4 PM-8 AM) each day for six days while on Time Restricted Arm.
- OTHER
-
Usual feeding pattern.
Participant consumes usual diet ad lib without enforced fasting period for six days while on Usual Feeding Pattern arm.
Sponsors & Collaborators
- collaborator OTHER
-
Rockefeller University
lead OTHER
Principal Investigators
-
Jose Aleman, MD, PhD · The Rockefeller University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-29
- Primary Completion
- 2025-08-04
- Completion
- 2025-08-04
Countries
- United States
Study Locations
More Related Trials
-
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
NCT06934707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
NCT07313384 ·Status: RECRUITING
-
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
NCT07272343 ·Status: RECRUITING ·Phase: PHASE4
-
GLP-1 Infusion and Long-Time Fasting
NCT00285896 ·Status: COMPLETED ·Phase: NA
-
Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
NCT01232491 ·Status: COMPLETED ·Phase: PHASE4
-
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
NCT05330247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
NCT04027023 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes
NCT06424106 ·Status: RECRUITING ·Phase: NA
-
Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes
NCT01977833 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of a Specific Enteral Diet for Diabetics
NCT01247714 ·Status: UNKNOWN ·Phase: NA
-
Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes
NCT04523155 ·Status: COMPLETED ·Phase: NA
-
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
NCT01722266 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
NCT05499702 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Diabetes Intervention Accentuating Diet and Enhancing Metabolism
NCT03225339 ·Status: COMPLETED ·Phase: NA
-
Short-term Effect of Intensive Insulin Therapy on Incretin Secretion
NCT00776243 ·Status: COMPLETED
-
Carbohydrates Under Target for Type 1 Diabetes Management
NCT04758858 ·Status: WITHDRAWN ·Phase: NA
-
Insulin and Insulin Pulses During Fasting
NCT06424015 ·Status: RECRUITING ·Phase: NA
-
Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study
NCT07141472 ·Status: COMPLETED ·Phase: NA
-
Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet
NCT03710928 ·Status: RECRUITING ·Phase: NA
-
Novel Type 2 Diabetes Mellitus Preventive Therapies
NCT02351323 ·Status: COMPLETED ·Phase: PHASE1
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
NCT00445627 ·Status: COMPLETED